These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Regional application of TNF alpha in the treatment of cancer: a preclinical-clinical interactive program. Eggermont AM; Manusama ER; ten Hagen TL J Inflamm; 1995-1996; 47(1-2):104-13. PubMed ID: 8913937 [TBL] [Abstract][Full Text] [Related]
13. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2). Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704 [TBL] [Abstract][Full Text] [Related]
15. [Tumor necrosis factor-alpha--biological and immunologic properties]. Chciałowski A; Targowski T; Bajera I; Jahnz-Rózyk K Pol Merkur Lekarski; 1997 Jun; 2(12):392-5. PubMed ID: 9424334 [TBL] [Abstract][Full Text] [Related]
16. Improving TNF as a cancer therapeutic: tailor-made TNF fusion proteins with conserved antitumor activity and reduced systemic side effects. Gerspach J; Pfizenmaier K; Wajant H Biofactors; 2009; 35(4):364-72. PubMed ID: 19484741 [TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-related apoptosis-inducing ligand pathway and its therapeutic implications. de Vries EG; Gietema JA; de Jong S Clin Cancer Res; 2006 Apr; 12(8):2390-3. PubMed ID: 16638843 [No Abstract] [Full Text] [Related]
18. Properties of monoclonal antibodies to human tumor necrosis factor alpha (TNF alpha). McLaughlin PJ; Elwood NJ; Russell SM; Andrew SM; McKenzie IF Anticancer Res; 1992; 12(4):1243-6. PubMed ID: 1503416 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13). Curnis F; Sacchi A; Borgna L; Magni F; Gasparri A; Corti A Nat Biotechnol; 2000 Nov; 18(11):1185-90. PubMed ID: 11062439 [TBL] [Abstract][Full Text] [Related]
20. TNFerade, an adenovector carrying the transgene for human tumor necrosis factor alpha, for patients with advanced solid tumors: surgical experience and long-term follow-up. McLoughlin JM; McCarty TM; Cunningham C; Clark V; Senzer N; Nemunaitis J; Kuhn JA Ann Surg Oncol; 2005 Oct; 12(10):825-30. PubMed ID: 16132372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]